These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7985692)

  • 1. Pharmacist adjustment of H2-receptor antagonist dosage to meet medical staff-approved criteria.
    Malcolm KE; Griffin CR; Bennett TA; Robertson LM
    Am J Hosp Pharm; 1994 Sep; 51(17):2152-4. PubMed ID: 7985692
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP; Briceland LL; Garris RE; Favreau BN
    Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria-based DUE aids in selection of preferred agent.
    Drea EJ
    Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a two-tiered therapeutic interchange policy.
    Rich DS
    Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
    Segal R; Oh T; Ben-Joseph R; Russell WL
    Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 9. Decision analysis applied to selection of histamine H2-receptor antagonists for the formulary.
    Calvo MV; Fruns I; Domínguez-Gil A
    Am J Hosp Pharm; 1990 Sep; 47(9):2002-6. PubMed ID: 1977316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriber identification program.
    Frighetto L; Bunz D; Jewesson P
    Can J Hosp Pharm; 1991 Feb; 44(1):35-6. PubMed ID: 10110042
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacy intern intervention to reduce costs associated with histamine H2-antagonist therapy.
    Algozzine GJ; Sprenger RL; Caselnova DA; Proper P
    Am J Hosp Pharm; 1989 Jun; 46(6):1183-4. PubMed ID: 2568750
    [No Abstract]   [Full Text] [Related]  

  • 12. Physician opinion of pharmacist-initiated change from injectable to oral administration of histamine H2-receptor antagonists.
    Kirking DM; Bickley SK; Wasserman ML
    Am J Hosp Pharm; 1991 Aug; 48(8):1722-7. PubMed ID: 1680293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an antibiotic restriction policy using a special drug request form.
    Julius HC; Beck K
    Hosp Formul; 1992 Jun; 27(6):638-40, 643. PubMed ID: 10118958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic-interchange program for oral histamine H2-receptor antagonists.
    Chase SL; Peterson AM; Wordell CJ
    Am J Health Syst Pharm; 1998 Jul; 55(13):1382-6. PubMed ID: 9659966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bar-code technology applied to drug-use evaluation.
    Zarowitz BJ; Petitta A; Mlynarek M; Touchette M; Peters M; Long P; Patel R
    Am J Hosp Pharm; 1993 May; 50(5):935-9. PubMed ID: 8099468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
    Coppola P
    Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case studies of hospital pharmacist involvement in managed care. Stanford University Hospital.
    Miller RF
    Am J Hosp Pharm; 1990 Oct; 47(10):2283-6. PubMed ID: 2248271
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician ID system relieves pharmacy woes.
    Hospitals; 1978 Jan; 52(1):14. PubMed ID: 618800
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical care role model in psychiatry--pharmacist prescribing.
    Ellenor GL; Dishman BR
    Hosp Pharm; 1995 May; 30(5):371-3, 377-8. PubMed ID: 10142376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.